346 related articles for article (PubMed ID: 15059889)
1. Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis.
Chan KS; Carbajal S; Kiguchi K; Clifford J; Sano S; DiGiovanni J
Cancer Res; 2004 Apr; 64(7):2382-9. PubMed ID: 15059889
[TBL] [Abstract][Full Text] [Related]
2. Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis.
Chan KS; Sano S; Kiguchi K; Anders J; Komazawa N; Takeda J; DiGiovanni J
J Clin Invest; 2004 Sep; 114(5):720-8. PubMed ID: 15343391
[TBL] [Abstract][Full Text] [Related]
3. Activation of the epidermal growth factor receptor by skin tumor promoters and in skin tumors from SENCAR mice.
Xian W; Kiguchi K; Imamoto A; Rupp T; Zilberstein A; DiGiovanni J
Cell Growth Differ; 1995 Nov; 6(11):1447-55. PubMed ID: 8562483
[TBL] [Abstract][Full Text] [Related]
4. Activation of epidermal akt by diverse mouse skin tumor promoters.
Lu J; Rho O; Wilker E; Beltran L; Digiovanni J
Mol Cancer Res; 2007 Dec; 5(12):1342-52. PubMed ID: 18171992
[TBL] [Abstract][Full Text] [Related]
5. Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: possible role in mouse skin tumor promotion.
Xian W; Rosenberg MP; DiGiovanni J
Oncogene; 1997 Mar; 14(12):1435-44. PubMed ID: 9136987
[TBL] [Abstract][Full Text] [Related]
6. Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis.
Chan KS; Sano S; Kataoka K; Abel E; Carbajal S; Beltran L; Clifford J; Peavey M; Shen J; Digiovanni J
Oncogene; 2008 Feb; 27(8):1087-94. PubMed ID: 17700521
[TBL] [Abstract][Full Text] [Related]
7. Altered expression of epidermal growth factor receptor ligands in tumor promoter-treated mouse epidermis and in primary mouse skin tumors induced by an initiation-promotion protocol.
Kiguchi K; Beltrán L; Rupp T; DiGiovanni J
Mol Carcinog; 1998 Jun; 22(2):73-83. PubMed ID: 9655251
[TBL] [Abstract][Full Text] [Related]
8. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
Kiguchi K; Bol D; Carbajal S; Beltrán L; Moats S; Chan K; Jorcano J; DiGiovanni J
Oncogene; 2000 Aug; 19(37):4243-54. PubMed ID: 10980598
[TBL] [Abstract][Full Text] [Related]
9. Alterations in cholesterol sulfate and its biosynthetic enzyme during multistage carcinogenesis in mouse skin.
Kiguchi K; Kagehara M; Higo R; Iwamori M; DiGiovanni J
J Invest Dermatol; 1998 Dec; 111(6):973-81. PubMed ID: 9856804
[TBL] [Abstract][Full Text] [Related]
10. Targeted disruption of TC-PTP in the proliferative compartment augments STAT3 and AKT signaling and skin tumor development.
Lee H; Kim M; Baek M; Morales LD; Jang IS; Slaga TJ; DiGiovanni J; Kim DJ
Sci Rep; 2017 Mar; 7():45077. PubMed ID: 28322331
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of susceptibility to diverse skin tumor promoters by activation of the insulin-like growth factor-1 receptor in the epidermis of transgenic mice.
Wilker E; Bol D; Kiguchi K; Rupp T; Beltrán L; DiGiovanni J
Mol Carcinog; 1999 Jun; 25(2):122-31. PubMed ID: 10365914
[TBL] [Abstract][Full Text] [Related]
12. Enhanced sensitivity to tumor growth and development in multistage skin carcinogenesis by transforming growth factor-alpha-induced epidermal growth factor receptor activation but not p53 inactivation.
Shibata MA; Ward JM; Green JE; Merlino G
Mol Carcinog; 1997 Mar; 18(3):160-70. PubMed ID: 9115586
[TBL] [Abstract][Full Text] [Related]
13. Naturally occurring phenolic acids modulate TPA-induced activation of EGFR, AP-1, and STATs in mouse epidermis.
Cichocki M; Dałek M; Szamałek M; Baer-Dubowska W
Nutr Cancer; 2014; 66(2):308-14. PubMed ID: 24380573
[TBL] [Abstract][Full Text] [Related]
14. Evidence for autocrine/paracrine growth stimulation by transforming growth factor-alpha during the process of skin tumor promotion.
Imamoto A; Beltrán LM; DiGiovanni J
Mol Carcinog; 1991; 4(1):52-60. PubMed ID: 2009135
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of the epidermal growth factor receptor and transforming growth factor-alpha during multistage skin carcinogenesis in SENCAR mice.
Rho O; Beltrán LM; Gimenez-Conti IB; DiGiovanni J
Mol Carcinog; 1994 Sep; 11(1):19-28. PubMed ID: 7916986
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase Cepsilon is linked to 12-O-tetradecanoylphorbol-13-acetate-induced tumor necrosis factor-alpha ectodomain shedding and the development of metastatic squamous cell carcinoma in protein kinase Cepsilon transgenic mice.
Wheeler DL; Ness KJ; Oberley TD; Verma AK
Cancer Res; 2003 Oct; 63(19):6547-55. PubMed ID: 14559850
[TBL] [Abstract][Full Text] [Related]
17. A novel mechanism of skin tumor promotion involving interferon-gamma (IFNγ)/signal transducer and activator of transcription-1 (Stat1) signaling.
Bozeman R; Abel EL; Macias E; Cheng T; Beltran L; DiGiovanni J
Mol Carcinog; 2015 Aug; 54(8):642-53. PubMed ID: 24464587
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of insulin-like growth factor I and its receptor during multistage carcinogenesis in mouse skin.
Rho O; Bol DK; You J; Beltrán L; Rupp T; DiGiovanni J
Mol Carcinog; 1996 Oct; 17(2):62-9. PubMed ID: 8890954
[TBL] [Abstract][Full Text] [Related]
19. Differential mechanism for the inhibition of epidermal growth factor binding to its receptor on mouse keratinocytes by anthrones and phorbol esters.
Imamoto A; Beltrán LM; DiGiovanni J
Carcinogenesis; 1990 Sep; 11(9):1543-9. PubMed ID: 2401043
[TBL] [Abstract][Full Text] [Related]
20. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha.
Greenhalgh DA; Wang XJ; Donehower LA; Roop DR
Cancer Res; 1996 Oct; 56(19):4413-23. PubMed ID: 8813135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
